3M Drug Delivery Systems and Panacea Pharmaceuticals have advanced their collaboration to deliver Panacea’s investigational cancer vaccine directly to the dermis via the 3M Hollow Microstructured Transdermal System (hMTS). The first patient in the Phase I clinical trial has been dosed with Panacea’s cancer vaccine using the hMTS.   “Panacea and 3M have had a great relationship and we’re excited to continue working with them,” said Silvia Perez, president and general manager of 3M Drug Delivery...